|
End-of-day quote
Nasdaq Stockholm
13/10/2026
|
5-day change | 1st Jan Change | ||
| 3.390 SEK | -1.88% |
|
-4.10% | -26.30% |
| 10-13 | Active Biotech completes first safety cohort in study of tasquinimod | FW |
| 10-13 | Active Biotech completes first safety cohort in myelofibrosis study | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACTIVE BIOTECH AB | Bio Therapeutic Drugs | -1.88% | -4.10% | -26.30% | -78.27% | -97.51% | 8.23M |  | | |
- Stock Market
- Stocks
- ACTI Stock
- Charts Active Biotech AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
